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Introduction
Mutations in the tumor suppressor breast cancer–associated 
  protein 1 (BRCA1) are associated with a high risk of breast and 
ovarian cancer. BRCA1 is a nuclear protein implicated in multiple 
processes, including genomic stability, transcription regulation, 
chromatin remodeling, and cell-cycle control (Starita and Parvin, 
2003; for reviews see Welcsh and King, 2001; Deng and Wang, 
2003). In normal S-phase cells, BRCA1 shows a punctate distribu-
tion with typically  10–20 prominent accumulations (foci), but 
upon induced DNA damage, it relocalizes to sites of DNA repair 
(Scully et al., 1997b; Tashiro et al., 2000; Cantor et al., 2001). 
Although many studies have investigated BRCA1 foci in relation 
to DNA repair, little is known about the BRCA1 foci in nonirradi-
ated cells. These have been suggested to be storage sites or, possibly, 
sites of endogenous damage. They are not thought to be sites of 
DNA replication because they distribute in a pattern distinct from 
that of replicating DNA (Scully et al., 1997a). However, it remains 
an important consideration that normal S-phase BRCA1 foci may 
refl  ect an unrecognized, but fundamental, function of BRCA1.
A key to understanding whether the BRCA1 foci in nonirra-
diated cells have biological signifi  cance is whether they form at 
specifi  c genomic loci. The spatial association of BRCA1 at sites of 
DNA damage provided key evidence for its role in DNA repair. 
We investigate whether BRCA1 foci in normal cells form at 
 specifi  c nuclear or chromosomal sites, or distribute more  randomly, 
as might be expected for storage sites or endogenous damage. 
BRCA1 localizes to the unpaired X and Y chromosomes in sper-
matocytes, implicating BRCA1 in recombination and meiotic 
  silencing (Scully et al., 1997b; Turner et al., 2004). However, in 
normal somatic nuclei there is no evidence that BRCA1 spots as-
sociate with specifi  c sites of chromatin, other than a reported asso-
ciation of BRCA1 with XIST RNA on the inactive X chromosome 
(Xi; Ganesan et al., 2002). Findings in this study demonstrate that 
BRCA1 foci form at particular classes of heterochromatin, linked 
to their replication, and suggest a novel role of BRCA1 with impli-
cations in the maintenance of genomic stability.
Results and discussion
In a fraction of cells, BRCA1 foci abut, 
but do not coat, the Xi
The report that BRCA1 colocalizes with XIST RNA on the 
inactive X chromosome (Xi) in a subset (5–10%) of cells 
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(Ganesan et al., 2002) led us to further investigate the spatial 
relationship between XIST RNA and BRCA1. In extensive in-
vestigation of multiple cell lines, using several BRCA1 antibod-
ies (see Materials and methods), we did not fi  nd that BRCA1 
substantially overlaps XIST RNA on Xi (Pageau et al., 2006; 
this study). However, using methods optimized for simultane-
ous detection of nuclear RNA and protein (see Materials and 
methods), BRCA1 partially overlapped or closely abutted XIST 
RNA in 3–5% of hundreds of cells viewed in 2D. 3D analysis 
of deconvolved optical sections (Fig. 1, A and B) shows that 
even in cases where BRCA1 and XIST RNA appear to overlap 
in 2D, they largely occupy distinct spatial territories, typically 
with BRCA1 tightly abutting the XIST signal (Video 1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200602055/DC1). 
BRCA1 also did not colocalize substantially with other hall-
marks of Xi-facultative heterochromatin (H3mK27 or ubiquitin; 
Fig. S1 A), which colocalize throughout the XIST RNA territory 
(Chaumeil et al., 2002; Smith et al., 2004). We also recorded a 
fraction of cells ( 13% in TIG1 fi  broblasts, with similar results 
for multiple cell lines) in which a BRCA1 spot was directly 
adjacent to, but clearly not overlapping (even by 2D analysis), 
XIST RNA (Fig. 2 D and not depicted; see Materials and meth-
ods for defi  nition of scoring terms). The signifi  cance of these 
more limited associations is investigated in this study. However, 
overall, these fi  ndings are consistent with other evidence that 
BRCA1 does not have a direct role in localizing XIST RNA 
(Pageau et al., 2006); if BRCA1 has a spatial relationship to the 
Xi, it is not via an association with XIST RNA.
Most BRCA1 foci localize 
to heterochromatic nuclear regions
To address whether the  10–20 prominent BRCA1 foci associate 
with a particular category of chromatin, we investigated whether 
they preferentially localize to the euchromatic or heterochromatic 
compartments. To delineate these compartments, we used hybrid-
ization to heterogeneous nuclear RNA (hnRNA) and labeling of 
splicing-factor–rich domains. Hybridization to hnRNA with a 
Cot-1 DNA probe delineates the inactive X chromosome (Hall 
et al., 2002) and heterochromatin abutting the nuclear envelope 
and nucleolus (Tam et al., 2004). Analysis, in two different cell 
lines, revealed a strong propensity for BRCA1 foci to localize in 
hnRNA-depleted regions; only  19% overlapped the Cot-1 RNA 
signal, which fi  lls most of the nucleoplasm (Fig. 2 A). A surpris-
ingly large fraction of BRCA1 foci ( 32%) localized to the 
Cot-1–depleted region abutting or within the nucleolus (Fig. 2 A). 
Another 14% localized to the peripheral heterochromatin, and 35% 
precisely colocalized with small discrete “holes” in the hnRNA 
signal (Fig. 2 A). Although not our focus in this study, an associa-
tion with the centrosome (Starita et al., 2004) was not noted with 
cells and antibodies used here. The association of BRCA1 with the 
nucleolus is interesting because many centromeres localize there.
The preference for heterochromatic regions contrasted to 
the paucity of BRCA1 foci with SC-35 and SRM300, which are 
splicing components that label 20–30 large domains linked to 
RNA metabolism. These regions are surrounded by active genes 
in the euchromatic compartment (Shopland et al., 2003). These 
BRCA1 foci only rarely overlap (<1%) or contact (3%) SC-35 
(Fig. 2 B) or SRM300 in mouse cells, suggesting they are 
largely excluded from these euchromatic “neighborhoods.”
BRCA1 has a substantial, but complex, 
relationship to mid-to-late replicating DNA
BRCA1 in normal S phase has not been thought to refl  ect routine 
DNA replication because BRCA1 distribution does not mirror 
that of replicating DNA (Scully et al., 1997a). We reexamined the 
relationship of BRCA1 foci to mid-to-late replicating DNA, 
Figure 1.  BRCA1 and XIST RNA/Xi relation-
ship in human female ﬁ  broblasts. (A and B, 
TIG1; C, WI38; D, IMR90). (A) An optical 
section from a deconvolved stack, followed 
by a line scan of the ﬂ  uorescence intensities. 
At right, 3D rendering with two views rotated 
 20 degrees is shown (Video 1). (B) Unpro-
cessed micrograph followed by a magniﬁ  ed 
view of a deconvolved optical slice show-
ing XIST RNA (red) and BRCA1 (green). (C) 
BRCA1 (green) and a replicating Barr body 
(BrdU, red; DAPI, blue). (D) X centromere 
(red) and BRCA1 (green) with DAPI (gray).
The DAPI-dense Barr differentiates Xa from 
Xi. Video 1 is available at http://www.jcb.org/
cgi/content/full/jcb.200602055.BRCA1 WITH REPLICATING PERICENTRIC HETEROCHROMATIN • PAGEAU AND LAWRENCE 695
which comprises largely heterochromatic DNA. Unlike the dis-
persed particulate pattern of early replication, the mid-to-late pat-
tern comprises a smaller number of larger spots (Nakayasu and 
Berezney, 1989; Quivy et al., 2004). Examination of whether 
BRCA1 foci overlapped BrdU spots confi  rmed the earlier conclu-
sion that, in general, the two patterns are not the same (Scully 
et al., 1997a). However, close scrutiny suggested a substantial, but 
incomplete, relationship. Approximately 3% of the discrete 
BRCA1 foci overlapped a BrdU spot, but an additional 18% were 
abutting or adjacent to (contacting) BrdU spots. Although these 
mid-to-late S-phase BrdU spots occupy a much smaller area of 
the nucleus than SC-35 domains (Fig. 2, B and C), BRCA1 shows 
greater spatial association with them. Many BRCA1 spots (an ad-
ditional  27%) seemed to position consistently close ( 0.3 μm) 
to a BrdU spot, the signifi  cance of which was initially unclear.
We also reexamined the relationship to the replicating Xi. 
As shown in Fig. 2 D, the subset of cells that showed BRCA1 
association (either abutting or adjacent; Fig. 1 C) during repli-
cation of Xi increased two- to threefold over asynchronous cul-
tures, which is consistent with an increased association in late 
S phase (Chadwick and Lane, 2005).
Many BRCA1 foci are spatially linked 
to components of the human interphase 
centromere–kinetochore complex
The aforementioned fi   ndings led us to investigate whether 
BRCA1 has a relationship to heterochromatin associated 
with centromeres. Using an antibody to centromere protein C 
(CENP-C), which is a constitutive component of the interphase 
centromere–kinetochore complex, the patterns of CENP-C and 
BRCA1 in human fi  broblasts (TIG1) were again distinct, yet 
exhibited a substantial spatial association (Fig. 3 A). We cat-
egorized these associations into three types, as follows: 3% of 
BRCA1 spots were completely coincident with CENP-C spots, 
another 12% directly abutted or contacted (no separation visible 
by light microscopy), and an additional 24% were suggestive 
of a close pairing. Very similar observations (3% coincident, 
14% abutting/adjacent, and 16% close) were made when we 
 hybridized  to  α-satellite DNA (Fig. 3 B) or used CENP-B, which 
binds α-satellite, as a marker (Fig. 3 C).
We next asked whether BRCA1 foci that abut Xi refl  ect 
a relationship to centromeres. The frequency with which we 
found BRCA1 partially overlaps ( 2%) or resides adjacent to 
(8%) the X centromere may largely account for BRCA1–XIST 
RNA association (3% partial overlap and 13% adjacent). Using 
the Barr body to distinguish the active and inactive X (Fig. 1 D), 
there was not a major difference in BRCA1 association with Xi 
versus active X chromosomes (Xa) centromeres (10% vs. 7%, 
respectively). Thus, the relationship of BRCA1 to Xi primarily 
refl   ects a relationship to centromere-associated constitutive 
heterochromatin, rather than specifi  cally Xi-facultative hetero-
chromatin. However, we do not exclude the possibility that the 
slightly higher association with Xi is caused by its more hetero-
chromatic nature.
Figure 2.  BRCA1 relationship to the heterochromatic compartment and replication in human ﬁ  broblasts. (A) BRCA1 (red) and Cot1 hybridization to 
hnRNA (green; DAPI, blue). (B) BRCA1 (green) and SC-35 domains (red). (C) BRCA1 (green) relative to BrdU-labeled, late-replicating DNA (red). (D and E) 
BRCA1 association increases during replication. (D) The replicating Xi in human cells was distinguished by BrdU and DAPI staining for the Barr body 
(n = 100). (E) Replicating mouse chromocenters were distinguished by PCNA label (n = 1100).JCB • VOLUME 175 • NUMBER 5 • 2006  696
The frequency with which BRCA1 signals either overlap 
or directly abut interphase centromere markers indicates a sub-
stantial, albeit incomplete, association. Although the “close, but 
not contacting” category is less clear, this could refl  ect a spatial 
linkage to some component of the centromere–kinetochore 
complex (for review see Cleveland et al., 2003), which has many 
components that do not all completely coincide in nuclei (Sugata 
et al., 2000) and are not all known. Therefore, the relatively con-
sistent gap between BRCA1 and CENP-C could contain some 
other component of this structure (see the following section).
BRCA1 structurally associates 
with mouse chromocenters 
and pericentric heterochromatin
Because BRCA1 most often “neighbors” (rather than overlaps) 
these centromere components, we next investigated BRCA1’s 
relationship to pericentric heterochromatin (PCH), which would 
also lie adjacent to centromeric DNA. Mouse cells have a more 
well-defi  ned organization of centric and pericentric DNA than 
do human cells (Schueler et al., 2001); in mouse cells, centro-
meres cluster into 5–10 chromocenters that are easily visualized 
with DAPI stain. Fig. S1 B confi  rms a recent report (Guenatri 
et al., 2004) demonstrating that the DAPI-dense chromocenters 
comprise pericentric heterochromatin (mouse major satellite) 
and the centromeric DNA (minor satellite) is smaller and posi-
tions at the periphery of the larger blocks of PCH.
BRCA1 staining revealed a clear structural relationship 
with chromocenters (Fig. 4 A). Although not all chromocenters 
have associated BRCA1, and vice versa, in all of the several 
different lines examined (mouse 3T3, 3X mouse, mouse em-
bryo fi   broblasts (MEFs), and mouse ES cells), 26–38% of 
BRCA1 spots in an asynchronous population directly associ-
ated with a chromocenter. In addition, a subpopulation of cells 
showed higher association; in some cells, almost all BRCA1 
spots were with a chromocenter (Fig. 4 A). Typically one or two 
BRCA1 foci were at the immediate periphery of each chromo-
center, but, not infrequently, several foci or elongated BRCA1 
accumulations “hugged” the contour of the chromocenter (Fig. 
4 A). Occasionally, a “paint” of nearly all the DAPI-bright PCH 
was apparent (Fig. 4 A, top middle). Interestingly, this associa-
tion is present even in very early (1-d differentiated) embryonic 
stem cells (Fig. 4 A, bottom right). This is potentially important 
because BRCA1 knockout is early embryonic lethal (Deng and 
Wang, 2003).
We next examined the relationship between BRCA1 and 
the minor satellite (equivalent of human α satellite) of the cen-
tromere proper. When visualized together (Fig. 4 B), their re-
lationship mirrored that seen (see previous section) between 
human centromeres and BRCA1, as follows: 6% coincident, 
10% adjacent/abutting, and 27% close. However, when viewed 
with DAPI in three colors, it became apparent that, often, mi-
nor satellite and BRCA1 signals that had no direct contact 
were in fact associated with a common chromocenter. These 
observations bolster the signifi  cance of close/“paired” signals 
in the human; even when the BRCA1 foci are not coincident 
with a centromeric marker, they are spatially linked by their 
common association with the PCH of the chromocenter (Fig. 
4 B and Video 2, available at http://www.jcb.org/cgi/content/
full/jcb.200602055/DC1). The link between BRCA1 and cen-
tric DNA may be through the PCH, but, in either case, results 
indicate a connection between the discrete BRCA1 S-phase foci 
and centromeres, which are structures key to the proper segre-
gation of chromosomes and maintenance of genomic integrity.
BRCA1 association with chromocenters 
is temporally linked to their replication
In both human and mouse, some cells show greater BRCA1 
association with chromocenters than others, as illustrated in 
Fig. 4 C (middle). We addressed whether this difference might 
relate to replication, using proliferating cell nuclear antigen 
(PCNA) as a marker of the replication machinery (Bravo, 1986). 
Chromocenters replicate roughly synchronously in a given cell 
Figure 3.  BRCA1 and human centromere mark-
ers in interphase ﬁ  broblasts. (A) BRCA1 (red) and 
CENP-C (green) in TIG1 cells. (B) BRCA1 (green) 
and centromeric DNA (red) in IMR90. (C) BRCA1 
(green) and CENP-B (red) in TIG1. Asterisks mark 
sites of association highlighted in insets and arrow-
heads mark some of the other sites of association.BRCA1 WITH REPLICATING PERICENTRIC HETEROCHROMATIN • PAGEAU AND LAWRENCE 697
in mid-to-late S phase (Fig. 4 C; Guenatri et al., 2004; Quivy 
et al., 2004). In cells in which most chromocenters had prominent 
PCNA label, a higher association of BRCA1 was clearly evident. 
Of chromocenters that label with PCNA, 55% have BRCA1 as-
sociated (15% overlap and 40% abutting), in contrast to <7% 
with no PCNA label (<1% overlap and 6% abutting; Fig. 2 E). 
Cells with the most striking BRCA1 painting of chromocenters 
also labeled for replication of the chromocenter. This demon-
strates a temporal relationship between widespread, largely 
synchronous BRCA1 association and replication of PCH.
Previous work has shown that mouse chromocenters have a 
defi  ned architecture such that DNA replication (and likely chro-
matin assembly) occurs at the periphery of the large major satellite 
block, and the newly replicated DNA then moves into the central 
region of the chromocenter (Quivy et al., 2004). This fi  ts well with 
the distribution of BRCA1, which is mostly concentrated at the chro-
mocenter periphery. Because BRCA1 did not always localize to 
PCNA-labeled chromocenters, it may transiently associate close 
to the time of replication. The fact that BRCA1 is more juxtaposed 
to PCNA than overlapping it is consistent with other evidence that 
BRCA1 may have a post-replicative role. Similar observations 
were made with a 15-min terminal pulse of BrdU (Fig. S1 C).
Because one recent study reports that BRCA1 regulates 
topoisomerase IIα (topoIIα) during routine DNA replication 
Figure 4.  BRCA1, mouse chromocenters, and the 
relationship to replication. (A) Mouse cell lines included 
MEFs (BRCA1, green), 3T3 (BRCA1, red), and mouse 
ES cells (BRCA1, green). (B) BRCA1 (red) and minor 
satellite DNA (green). Far right shows 3D-rendered im-
age of BRCA1 and minor satellite on a chromocenter 
(blue). Middle photo shows chromocenters in black. 
(C) Cells were labeled for replication with PCNA (red) 
and BRCA1 (green). In top panel, the upper nucleus 
has more BRCA1 and PCNA on chromocenters. 
(D and E) topoII-α (green) on mouse chromocenters 
(blue) is seen in many S-phase cells (PCNA, red).JCB • VOLUME 175 • NUMBER 5 • 2006  698
(Lou et al., 2005), we briefl  y addressed whether topoIIα asso-
ciates with mouse chromocenters. Although topoIIα is enriched 
at mitotic centromeres, and there is one report of its associa-
tion with late S-phase BrdU (Agostinho et al., 2004), it is not 
known to be enriched at chromocenters/centromeres during 
S phase. As shown in Fig. 4 D, we found topoIIα commonly en-
riched on mouse chromocenters; in  40% of interphase cells, 
topoIIα concentrates on essentially all chromocenters. Many 
of these cells are in S phase, with PCNA on their chromo-
centers (Fig. 4 E).
Initial characterization of BRCA1 mutant 
cells is suggestive of mitotic defects
Our fi  ndings suggest that BRCA1 may have a role in replica-
tion-linked maintenance of peri/centromeric heterochromatin. 
As the study of X inactivation has demonstrated, the epigen-
etic state of heterochromatin is controlled at numerous levels 
that work synergistically and provide redundancy; for example, 
heterochromatic features of the Xi are compromised only very 
slightly over the long term if XIST RNA is lost from somatic 
cells (Csankovszki, 2001). Similarly, reintroduction of XIST 
RNA in somatic cells would not simply correct a defi  cit in 
heterochromatin (Wutz and Jaenisch, 2000; Hall et al., 2002). 
Thus, short-term loss or gain of BRCA1 could have no   immediate 
effect on heterochromatin but still be important for its long-term 
maintenance and stability in an organism. We found that short-
term acute loss of BRCA1 by RNAi in HeLa cells impacts pro-
liferation and reduces mitotic fi  gures by >60% (Fig. S2, avail  able 
at http://www.jcb.org/cgi/content/full/jcb.200602055/DC1), 
which is consistent with other reports. Although this could 
refl  ect an impact on the complex epigenetic state or repair of 
pericentric heterochromatin, it could also refl  ect other short-
term effects of BRCA1 loss on centrosome function (Starita 
et al., 2004), DNA decatenation (Lou et al., 2005), or cell-cycle 
checkpoints (Cao et al., 2003; Deng and Wang, 2003).
Breast tumor cells such as HCC1937 are exposed to 
  longer-term BRCA1 loss. As an initial effort to investigate some 
properties of centric heterochromatin, we examined CENP-A, 
a constitutive interphase kinetochore component directly linked 
to specifying a centromeric property, and CENP-F, the fi  rst tran-
sient kinetochore protein bound in G2 (Maiato et al., 2004). 
  Localization of these centromeric components appeared normal 
in these BRCA1 mutant cells (Fig. 5 A). However, given the 
  essential role of CENP-A in kinetochore assembly, this may not 
be surprising.
Lou et al. (2005) reported that a high fraction ( 10%) of 
HCC1937 cells had lagging chromosomes or DNA bridges after 
mitosis. We attempted to confi  rm these fi  ndings, but extended 
our analysis to MCF7 (BRCA1+) breast cancer cells and nor-
mal diploid fi  broblasts. It was obvious in DAPI-stained slides of 
HCC1937 that many early G1 daughter pairs contain a “bridge” 
of DNA extending between them (Fig. 5 B); in contrast, this 
was almost never seen in BRCA1+ MCF7 or in normal fi  bro-
blasts. Many mitotic fi  gures showed lagging chromosomes, and 
early G1 pairs showed thin bridges of DNA. For example, in 
100 G1 daughter pairs, visible DNA bridges were seen 31 times 
in HCC1937 cells, in contrast to 3 times in diploid fi  broblasts 
(TIG1) and 4 times in MCF7 cells. Most mitotic fi  gures with 
Figure 5.  Centromeric markers and DNA bridges in BRCA1−/− HCC1937 cells. (A) TIG1 (left) and HCC1937 cells (right) stained for CENP-A and -F. 
(B) In HCC1937 early G1 daughter cells, DAPI staining shows thin DNA bridges. (C) Centromeric DNA (green) in DNA bridges (left and right) and lagging 
chromosomes (middle) in HCC1937 cells.BRCA1 WITH REPLICATING PERICENTRIC HETEROCHROMATIN • PAGEAU AND LAWRENCE 699
lagging chromosomes showed a normal bipolar confi  guration; 
thus, in most cases, a multipolar spindle (i.e., centrosome) de-
fect was not apparent. Although we did not observe an appre-
ciable difference in mitotic defects in a BRCA1-reconstituted 
HCC1937 cell line (Lou et al., 2005), as noted earlier, once any 
defects in PCH or aneuploid cells are generated, reversion to 
normal mitotic fi  gures would be diffi  cult. Finally, we addressed 
whether the thin bridges connecting G1 daughters contained 
satellite DNA. Although many DNA bridges were just thin threads, 
a large fraction (35/40) contained α-satellite DNA (Fig. 5 C). 
These results are consistent with the possibility that a defect 
in centric/pericentric heterochromatin is present.
Conclusions
Although BRCA1 nuclear distribution has been studied for 
some time, this is the fi   rst study to identify a preferential 
  relationship with centric and pericentric heterochromatin, and 
link this   temporally to replication of these structures (sum-
marized in Table I). This may have escaped earlier detection 
because BRCA1 distribution does not simply mirror that of 
replicating DNA, but we show there is indeed a meaningful 
relationship suggesting a novel biological role for BRCA1. 
Because most ( 80%) of the bright BRCA1 foci localize to 
hnRNA-depleted sites, those not with peri/centric DNA may be 
mostly with some other heterochromatin (e.g., telomeres, etc). 
The widespread, largely synchronous localization of BRCA1 
foci to mouse chromocenters suggests a link to routine replica-
tion rather than just repair, but the highly repetitive (or con-
densed) nature of this DNA poses specifi  c requirements that 
may involve repair-related or other BRCA1 functions (e.g., 
chromatin remodeling/assembly, transcriptional regulation, or 
topoII-mediated roles).
This work points to a new direction of BRCA1 research 
involving routine replication and maintenance of peri/centric 
heterochromatin. Although a specifi  c role of BRCA1 requires 
further investigation, any involvement of BRCA1 in maintain-
ing centric/pericentric heterochromatin would have profound 
signifi  cance for understanding how BRCA1 mutations contrib-
ute to genomic instability and cancer. This study also clarifi  es 
an earlier report that BRCA1 appeared to have an extensive 
and specifi  c relationship to XIST RNA and Xi facultative het-
erochromatin (Ganesan et al., 2002). Recent studies from the 
Livingston laboratory, and other laboratories, indicate that mi-
totic loss of the Xi and gain of an Xa is the most common 
means whereby X chromosome dosage is increased in certain 
types of breast cancers (Sirchia et al., 2005; Richardson et al., 
2006). Therefore, the demonstration in this study that BRCA1 
associates with constitutive more than facultative heterochro-
matin fi  ts well with recent evidence that the most prevalent 
mechanism of Xi loss in BRCA−/− cancer may involve in-
creased errors in chromosome segregation. Additionally, loss 
of BRCA1 may contribute to a generalized failure of hetero-
chromatin maintenance.
Materials and methods
Cells and cell culture
Human diploid ﬁ   broblast lines WI38 (CCL-75) and IMR-90 (CCL-186) 
were obtained from the American Type Culture Collection, and TIG-1 
(AG06173) were obtained from Coriell Cell Repositories. In addition, 3X 
mouse cells (Smith et al., 2004) and MCF7 cells were used. WI38, TIG-1, 
MCF7, and 3X mouse cells were grown in MEM supplemented with 10% 
FBS, 2 mM L-glutamine, 1% penicillin/streptomycin, NIH 3T3 cells, and 
MEFs and were grown in DME supplemented with 10% FBS, 2 mM L-gluta-
mine, and 1% penicillin/streptomycin. HCC1937 cells were obtained from 
American Type Culture Collection (CRL-2336) and were grown in RPMI 
with Hepes medium supplemented with 10% FBS, 2 mM L-glutamine, and 
1% penicillin/streptomycin. For BrdU labeling, cells were plated for 48 h, 
followed by a 15-min treatment with 30 μM BrdU just before ﬁ  xation. 
HCC1937 cells reconstituted with BRCA1 were obtained from J. Chen 
(Mayo Clinic, Rochester, MN; Lou et al., 2005).
Antibodies
Monoclonal antibodies to mouse (GH118) and human (MS110) BRCA1 
were a gift from D. Livingston and S. Ganesan (The Dana Farber Cancer 
  Institute, Boston, MA; Ganesan et al., 2002). A monoclonal antibody to 
polyubiquitinated proteins (UbFk2) was obtained from Afﬁ  niti BioReagents. 
  Polyclonal antibodies to BRCA1 (KAPST0201) were obtained from Assay 
Designs and C. Deng (National Institutes of Health, Bethesda, MD). Antibodies 
to BrdU (rat monoclonal) were obtained from Harlan. Polyclonal antibodies 
to CENP-C (rabbit) were obtained from W. Earnshaw (University of   Edinburgh, 
Edinburgh, UK), and CENP-B antibodies (rabbit; H-65) were obtained 
from Santa Cruz Biotechnology, Inc. An antibody to CENP-A was obtained 
from M. Valdivia (Universidad de Cadiz, Cadiz, Spain), and an antibody to 
CENP-F was obtained from D. Cleveland (University of California, San 
Diego, La Jolla, CA). Antibodies to PCNA were obtained from Immunovision 
(Human). An antibody to topoIIα was obtained from Lab Vision (rabbit).
Immunoﬂ  uorescence
Initial studies involved testing two ﬁ  xation methods; paraformaldehyde ﬁ  x-
ation followed by Triton X-100 extraction, as described by Ganesan et al. 
(2002), or brief Triton X-100 extraction before ﬁ  xation, as described previ-
ously (Clemson et al., 1996; Tam et al., 2004). For extraction, cells were 
extracted in CSK buffer with 0.5% Triton X-100 and 2 mM vanadyl adenos-
ine for 5 min. Cells were then ﬁ  xed in 4% paraformaldehyde in 1×PBS for 
10 min, incubated with primary antibodies in 1×PBS/1% BSA for 1 h at 
37°C, and rinsed successively in 1×PBS, 1×PBS + 0.1% Triton X-100, 
and 1×PBS for 10 min. Detection was carried out with secondary antibod-
ies tagged with ﬂ  uorescein, rhodamine, or Texas red (Jackson Immuno-
Research Laboratories).
DNA and RNA FISH
RNA FISH used previously established protocols (Clemson et al., 1996; 
for review see Tam et al., 2004). XIST RNA was detected with a 10-kb 
Table I. Association of BRCA1 foci with various nuclear compartments
Nuclear compartment/
structure
Association (contact) of BRCA1 foci with 
compartment/structure
XIST RNA Little overlap, but up to 16% contacting
Replicating Xi 
 (BrdU-labeled Barr body)
Frequency of association increases over 
 asynchronous population
Heterochromatic, 
 hnRNA(Cot1)-depleted regions 
Overwhelmingly associated (81%)
SC-35 domains 
 within euchromatin
Overwhelmingly separate ( 95% apart)
Late-replicating DNA Mostly abutting or adjacent, 21% 
Human interphase centromere 
 markers similar for CENP-B, -C, 
 and α-satellite
Mostly abutting or adjacent, 15–17%
Mouse chromocenters (DAPI) 
 corresponding to major satellite
Mean association (26–38%) with some 
 cells much higher (>75%) association
Replicating chromocenter Much higher association (mean 55%)
Xi and Xa centromere  Association with both Xi (10%) and Xa (7%)
The frequency of discrete accumulations (foci) of BRCA1 was scored relative to the 
nuclear marker, typically in hundreds of cells. Most analysis was in 2D directly through 
the microscope, but certain results were conﬁ  rmed by 3D analysis as described in the 
text. Only accumulations of BRCA1 clearly above background were scored; we do not 
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plasmid (pG1A) spanning intron 4 to the 3′ end of XIST, or with plasmid 
(pXISTHb-B) containing intron 1 (Clemson et al., 1996). Probes were nick 
translated using biotin-11-dUTP or digoxigenin-6-dUTP (Boehringer 
Mannheim). Hybridization was detected with either antidigoxigenin anti-
body (Boehringer Mannheim) coupled with rhodamine or ﬂ  uorescein or, 
for biotin detection, avidin conjugated to Alexa Fluor–streptavidin 594 
(red) or ﬂ  uorescein (Boehringer Mannheim). RNAsin was added for simul-
taneous RNA FISH and antibody staining. After detection and washing, 
cells were re-ﬁ  xed in 4% paraformaldehyde in PBS for 10 min at 25°C and 
processed for RNA FISH as described in this section.
For combined BRCA1 staining and DNA FISH, cells were stained 
ﬁ  rst for BRCA1 and ﬁ  xed in 4% paraformaldehyde for 10 min. Cells were 
then denatured in 0.2 N NaOH for 5 min at room temperature (rather than 
70% formamide with heat) because this better preserved BRCA1 staining. 
A probe directed against all human centromeres (Open Biosystems Human 
Pancentromere Paint BIOTIN) was obtained from Cambio and hybridized 
overnight at 37°C as directed by the manufacturer and detected with Alexa 
red streptavidin diluted 1:500 in 4×SSC/1% BSA. Oligos (5′-G  A  A  C  A  G  T-
G  T  A  T  A  T  C  A  A  T  G  A  G  T  T  A  C  -3′ and 5′-C  C  A  C  A  C  T  G  T  A  G  A  A  C  A  T  A  T  T  A  G  A  T  G  -3′) 
to the mouse minor satellite were used at 5 pmol in 10% formamide. The 
X centromere was labeled with a Spectrum Orange X centromere paint 
  (Vysis) according to the manufacturer’s directions and rinsed as described 
in the previous paragraph.
Microscopy and image analysis
Digital imaging analysis was performed using an Axiovert 200 or an 
  Axiophot microscope (Carl Zeiss MicroImaging, Inc.) equipped with a 100× 
PlanApo objective (NA 1.4; Carl Zeiss MicroImaging, Inc.) and 83,000 
multibandpass dichroic and emission ﬁ  lter sets (Chroma Technology Corp.) 
set up in a wheel to prevent optical shift. Images were captured with a 
camera (Orca-ER; Hamamatsu) or a cooled charge-coupled device camera 
(200 series; Photometrics). Where rhodamine was used for detection in 
red, a narrow band-pass ﬂ  uorescein ﬁ  lter was inserted to correct for any 
bleed-through of rhodamine ﬂ   uorescence into the ﬂ   uorescein channel. 
Optical sections and 3D images were created using Axiovision 4.4 (Carl 
Zeiss MicroImaging, Inc.). Images were captured at 0.1-μm intervals, and 
stacks were deconvolved with a constrained iterative algorithm. Rendered 
images are maximum value projections.
Deﬁ  nition of molecular cytology scoring terms
For scoring purposes, the following deﬁ  nitions are used for scoring terms: 
association indicates any relationship that appears to involve “contact” (no 
physical separation visible by 2D light microscopy). These were further di-
vided into three categories of association. (1) Painting, which typically in-
dicates almost complete overlap of two signals, but in this analysis any 
overlap >50% would have been included. (2) Abutting/partial overlap, 
which indicates a signal which very closely pressed against another, such 
that as viewed in two dimensions there appears a slight overlap of the two 
signals. 3D analysis may show the two signals are actually not overlapping. 
(3) Adjacent, which indicates two signals that are juxtaposed and appear 
in contact, but for which even 2D analysis indicates no overlap. “Closely 
paired” signals are distinct in that this category indicates two signals that 
do not contact, but are separated by  0.2–0.4 μm.
Online supplemental material
Fig. S1 shows hallmarks of X inactivation on the Xi, localization of 
  major and minor satellite DNA relative to chromocenters, and localization 
of BRCA1 and BrdU to mouse chromocenters. Fig. S2 shows decreased 
proliferation in BRCA1 siRNA-treated versus control siRNA-treated cells 
and contains RNAi methods. Video 1 is a 3D movie of BRCA1 and 
XIST. Video 2 is a 3D movie of BRCA1 and a mouse chromocenter. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200602055/DC1.
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